A Publication for the Practising Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Clinical Trials

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

“The Decipher Prostate test’s ability to help guide treatment for patients with localized prostate cancer is already proven in dozens of peer-reviewed publications and is the only molecular test to achieve ‘Level 1B’ evidence status in the most recent NCCN® Guidelines* for prostate cancer,” said Elai Davicioni, Ph.D., Veracyte’s medical director for Urology. “These new phase 3 data from the STAMPEDE trial now further prove the performance and utility of our test in patients with metastatic prostate cancer. We believe our test can have a tremendous positive impact on care for these patients.”

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer

“This analytical validation study strongly complements EsoGuard’s extensive peer-reviewed, published clinical validity and clinical utility evidence base,” said Suman Verma, M.D., PhD, Chief Scientific Officer at Lucid Diagnostics. “The results demonstrate very robust analytical performance of the EsoGuard assay performed in our CLIA-certified, CAP-accredited, NY State-approved commercial laboratory.”

Biotechnology News

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

“The submission of the BLA marks a pivotal step for Capricor Therapeutics and those impacted by DMD. This BLA is the culmination of a body of work that has been focused on bringing this potentially transformational therapy to those patients in need,” said Linda Marbán, Ph.D., Chief Executive Officer of Capricor. “We believe that the strength of this application is that deramiocel has shown in multiple clinical trials attenuation of the cardiac implications of DMD. We look forward to working with the FDA throughout the review process to support this potential approval.”

PharmaEssentia Reaffirms its Commitment to Robust and Reliable Access to Interferon Therapies Amid Global Supply Challenges

“Our longstanding commitment to operational resilience has positioned us to navigate these challenges effectively,” said Dr. Ko Chung Lin, CEO of PharmaEssentia. “We recognize that dependable medication supply is essential, and we are working closely with our partners around the world to ensure the continuity of these important therapies. We have made substantial investment to ensure that all of our supply chain elements are strong, of the highest quality, and reliable.”

YolTech Therapeutics Granted FDA Orphan Drug and Rare Pediatric Disease Designations for YOLT-203 to Treat Primary Hyperoxaluria Type 1

After reviewing YolTech Therapeutics submission, the FDA determined that the therapy is not only appropriate for primary hyperoxaluria type 1 (PH1), but also applicable to the broader category of primary hyperoxaluria (PH). As a result, the designations were granted for PH, reflecting the expanded scope of the therapy’s potential impact. These dual designations underscore the transformative potential of YOLT-203 to address this rare and life-threatening genetic disorder.

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Matter Bio Successfully Closes $7M Seed Funding Round

“Genomic integrity is a cornerstone of longevity and healthspan extension,” said George Church, Professor of Genetics at Harvard Medical School. “Matter Bio is pioneering a crucial approach in the fight against aging by focusing on the preservation of our genetic blueprint. I am excited to see the impact of their work on enhancing human health.”

Enifer Secures €36M In Funding

Enifer, a biotech scaleup is gearing up the production of its PEKILO® mycoprotein with a new €33M factory located in Kirkkonummi, Finland. With already existing collaborations with the world’s leading food and feed companies, Enifer is prepared to annually upcycle food industry side streams into up to 3,000 tons of its sustainable fungi-based protein

Market Reports

Advancements in Imaging

Vieworks

Vieworks Showcases X-ray Imaging Excellence: RSNA 2023 Spotligh

Vieworks will present its comprehensive range of DR flat panel detectors (FPDs) catering to general radiography, dynamic applications, and mammography. The focal point remains on the latest VIVIX-S F series, accompanied by the revolutionary VIVIX-S 1751S—a long-format detector tailored for imaging larger body parts and long bones.

Samsung

Samsung Ushers in a New Era of Diagnostic Solutions at RSNA 2023

The clinical launch of the OmniTom Elite with PCD, the first US FDA 510(k) cleared single-source photon counting computed tomography scanner with a single detector on a mobile system, will be featured at this year’s meeting. Photon counting is a next-generation CT technology that sorts the different energies of X-rays after they have passed through the scan field, capturing the X-ray photons directly at the detector and converting the energy to electrical signals.

EVIS X1 Endoscopy System

Olympus Announces Market Launch of EVIS X1 Endoscopy System

The EVIS X1 endoscopy system received clearance earlier this year along with two compatible endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within the lower digestive tract.

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare - Understanding the Business Side of the Industry and Its Implications

Private Practice Management

Streamlining Private Practice Management in the Digital Age

The healthcare field is changing fast. Many hospitals and companies are buying up about 14,000 independent practices in 2021. To compete as a private practice, it’s crucial to use technology. Things like virtual care platforms can make medical tasks easier. By using these, private practices can focus on providing excellent patient care.

10 Key Vulnerabilities in the Global Pharmaceutical Supply Chain

The global pharmaceutical supply chain, while essential for modern commerce and interconnected economies, is riddled with vulnerabilities that can disrupt the flow of goods and services, leading to economic instability and potential crises. These vulnerabilities have been highlighted by various events in recent years, such as the COVID-19 pandemic and cyberattacks on critical infrastructure. Here are 10 key vulnerabilities of the global supply chain

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.